ARAIX
Price
$87.29
Change
-$1.07 (-1.21%)
Updated
Aug 17 closing price
Net Assets
3.06B
JVMAX
Price
$30.25
Change
-$0.22 (-0.72%)
Updated
Aug 17 closing price
Net Assets
24.41B
Interact to see
Advertisement

ARAIX vs JVMAX

ARAIX vs JVMAX Comparison Chart in %
View a ticker or compare two or three
VS
ARAIX vs. JVMAX commentary
Aug 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAIX is a Buy and JVMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMAX has more cash in the bank: 24.4B vs. ARAIX (3.06B). JVMAX pays higher dividends than ARAIX: JVMAX (0.48) vs ARAIX (0.10). ARAIX was incepted earlier than JVMAX: ARAIX (15 years) vs JVMAX (29 years). JVMAX (1.11) is less costly to investors than ARAIX (0.70). JVMAX is a more actively managed with annual turnover of: 48.00 vs. ARAIX (17.00). JVMAX has a lower initial minimum investment than ARAIX: JVMAX (1000) vs ARAIX (1000000). ARAIX annual gain was more profitable for investors over the last year : 15.28 vs. JVMAX (9.92). JVMAX return over 5 years is better than : 15.31 vs. ARAIX (3.79).
ARAIXJVMAXARAIX / JVMAX
Total Expense Ratio0.701.1064%
Annual Report Gross Expense Ratio0.701.1163%
Fund Existence15 years29 years-
Gain YTD19.24418.238106%
Front LoadN/A5%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.06B24.4B13%
Annual Yield % from dividends0.100.4822%
Returns for 1 year15.289.92154%
Returns for 3 years30.5124.69124%
Returns for 5 years3.7915.3125%
Returns for 10 years48.7758.6383%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SZCRX59.950.42
+0.71%
DWS Small Cap Core R6
TSMUX20.000.13
+0.65%
Nuveen Quant Small/Mid Cap Eq W
VEVYX52.690.15
+0.29%
Victory Sycamore Established Value Y
JMNSX15.410.01
+0.06%
JPMorgan Research Market Neutral I
BSGIX17.19-0.03
-0.17%
Baird Small/Mid Cap Growth Institutional